Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance

International Journal of Obesity

Volumn 33, Issue 7, 2009, Pages 775-785

  Semjonous, N M ^a   Smith, K L ^a   Parkinson, J R C ^a   Gunner, D J L ^a   Liu, Y L ^a   Murphy, K G ^a   Ghatei, M A ^a   Bloom, S R ^a   Small, C J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Energy expenditure; Food intake; Hypothalamus; Neuropeptide

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; CORTICOTROPIN RELEASING FACTOR; MELANIN CONCENTRATING HORMONE; NEUROMEDIN U; NEUROPEPTIDE; OREXIN A; PEPTIDE YY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD DEPRIVATION; HYPOTHALAMUS; MALE; NONHUMAN; NUTRITIONAL STATUS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; ANIMAL; BODY WEIGHT; DRUG EFFECTS; ENERGY METABOLISM; METABOLISM; NERVE CELL; WISTAR RAT;

ANIMALS; BODY WEIGHT; ENERGY INTAKE; ENERGY METABOLISM; HYPOTHALAMUS; MALE; NEURONS; NEUROPEPTIDES; RATS; RATS, WISTAR;

AGOUTI; RATTUS;

EID: 67650383433     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.96     Document Type: Article

References (49)

1. Broberger C, Visser TJ, Kuhar MJ, Hokfelt T. Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology 1999; 70: 295-305.
2. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 1.
3. Vaughan JM, Fischer WH, Hoeger C, Rivier J, Vale W. Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 1989; 125: 1660-1665.
4. Hashimoto K, Ohno N, Aoki Y, Kageyama J, Takahara J, Ofuji T. Distribution and characterization of corticotropin-releasing factor and arginine vasopressin in rat hypothalamic nuclei. Neuroendocrinology 1982; 34: 32-37.
5. Howard AD, Wang R, Pong SS, Mellin TN, Strack A, Guan XM et al. Identification of receptors for neuromedin U and its role in feeding. Nature 2000; 406: 70-74.
6. Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, Bloom SR. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 1999; 160: R7-12.
7. Smith KL, Patterson M, Dhillo WS, Patel SR, Semjonous NM, Gardiner JV et al. Neuropeptide S stimulates the hypothalamopituitary- adrenal axis and inhibits food intake. Endocrinology2006; 147: 3510-3518.
8. Blaxter KL. Energy Metabolism in Animals and Man. CUP Archive, Chapter 8. The Minimal Metabolism, 1989, pp120-145.
9. Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D et al. A C-terminal fragment of agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 1998; 139: 4428-4431.
10. Abbott CR, Rossi M, Kim M, AlAhmed SH, Taylor GM, Ghatei MA et al. Investigation of the melanocyte stimulating hormones on food intake. Lack of evidence to support a role for the melanocortin-3-receptor. Brain Res 2000; 869: 203-210.
11. Negri L, Noviello L, Noviello V. Effects of sauvagine, urotensin I and CRF on food intake in rats. Peptides 1985; 6 (Suppl 3): 53-57.
12. Rossi M, Choi SJ, O'Shea D, Miyoshi T, Ghatei MA, Bloom SR. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology1997; 138: 351-355.
13. Le Magnen J, Tallon S. [The spontaneous periodicity of ad libitum food intake in white rats]. J Physiol (Paris) 1966; 58/3: 323-349.
14. Le Magnen J. Peripheral and systemic actions of food in the caloric regulation of intake. Ann NY Acad Sci 1969; 157: 1126-1157.
15. Strubbe JH, Spiteri NJ, Alingh Prins AJ. Effect of skeleton photoperiod and food availability on the circadian pattern of feeding and drinking in rats. Physiol Behav 1986; 36: 647-651.
16. Spiteri NJ, Prins AA, Keyser J, Strubbe JH. Circadian pacemaker control of feeding in the rat, at dawn. Physiol Behav 1982; 29: 1141-1145.
17. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ et al. Hypothalamic localization of the feeding effect of agoutirelated peptide and alpha-melanocyte-stimulating hormone. Diabetes 2000; 49: 177-182.
18. Abbott CR, Kennedy AR, Wren AM, Rossi M, Murphy KG, Seal LJ et al. Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology2003; 144: 3943-3949.
19. Lawrence CB, Liu YL, Stock MJ, Luckman SM. Anorectic actions of prolactin-releasing peptide are mediated by corticotropinreleasing hormone receptors. Am J Physiol Regul Integr Comp Physiol 2004; 286: R101-R107.
20. Wirth MM, Giraudo SQ. Agouti-related protein in the hypothalamic paraventricular nucleus: effect on feeding. Peptides 2000; 21: 1369-1375.
21. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984; 115: 427-429.
22. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278: 135-138.
23. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996; 380: 243-247.
24. Goldstone AP, Unmehopa UA, Bloom SR, Swaab DF. Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. J Clin Endocrinol Metab 2002; 87: 927-937.
25. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 1991; 260 (Part 2): R321-R327.
26. Egawa M, Yoshimatsu H, Bray GA. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol 1991; 260 (Part 2): R328-R334.
27. Fekete C, Kelly J, Mihaly E, Sarkar S, Rand WM, Legradi G et al.Neuropeptide Y has a central inhibitory action on the hypothalamic- pituitary-thyroid axis. Endocrinology 2001; 142: 2606-2613.
28. Schuhler S, Warner A, Finney N, Bennett GW, Ebling FJ, Brameld JM. Thyrotrophin-releasing hormone decreases feeding and increases body temperature, activity and oxygen consumption in Siberian hamsters. J Neuroendocrinol 2007; 19: 239-249.
29. Griffiths EC, Rothwell NJ, Stock MJ. Thermogenic effects of thyrotrophin-releasing hormone and its analogues in the rat. Experientia 1988; 44: 40-42.
30. Hagan JJ, Leslie RA, Patel S, Evans ML,Wattam TA, Holmes S et al.Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999; 96: 10911-10916.
31. Monda M, Viggiano A, Viggiano A, Viggiano E, Messina G, Tafuri D et al. Sympathetic and hyperthermic reactions by orexin A: role of cerebral catecholaminergic neurons. Regul Pept 2007; 139: 39-44.
32. Morley JE, Levine AS. Corticotrophin releasing factor, grooming and ingestive behavior. Life Sci 1982; 31: 1459-1464.
33. Dunn AJ, Berridge CW, Lai YI, Yachabach TL. CRF-induced excessive grooming behavior in rats and mice. Peptides 1987; 8: 841-844.
34. de GL, Penalva RG, Flachskamm C, Reul JM, Linthorst AC. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists. J Neurochem 2005; 94: 45-56.
35. Linthorst AC, Penalva RG, Flachskamm C, Holsboer F, Reul JM. Forced swim stress activates rat hippocampal serotonergic neurotransmission involving a corticotropin-releasing hormone receptor-dependent mechanism. Eur J Neurosci 2002; 16: 2441-2452.
36. Egawa M, Yoshimatsu H, Bray GA. Effect of corticotropin releasing hormone and neuropeptide Y on electrophysiological activity of sympathetic nerves to interscapular brown adipose tissue. Neuroscience 1990; 34: 771-775.
37. Hanada R, Nakazato M, Murakami N, Sakihara S, Yoshimatsu H, Toshinai K et al. A role for neuromedin U in stress response. Biochem Biophys Res Commun 2001; 289: 225-228.
38. Yokota M, Ozaki Y, Sakamoto F, Yamada S, Saito J, Fujihara H et al.Fos expression in CRF-containing neurons in the rat paraventricular nucleus after central administration of neuromedin U. Stress 2004; 7: 109-112.
39. Hanada T, Date Y, Shimbara T, Sakihara S, Murakami N, Hayashi Y et al. Central actions of neuromedin U via corticotropin-releasing hormone. Biochem Biophys Res Commun 2003; 311: 954-958.
40. Wren AM, Small CJ, Abbott CR, Jethwa PH, Kennedy AR, Murphy KG et al. Hypothalamic actions of neuromedin U. Endocrinology2002; 143: 4227-4234.
41. Poggioli R, Vergoni AV, Bertolini A. ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides 1986; 7: 843-848.
42. Fekete C, Legradi G, Mihaly E, Huang QH, Tatro JB, Rand WM et al. Alpha-melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormonesynthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin- releasing hormone gene expression.. J Neurosci 2000; 20: 1550-1558.
43. Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM et al. The central melanocortin system affects the hypothalamopituitary thyroid axis and may mediate the effect of leptin. J Clin Invest 2000; 105: 1005-1011.
44. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjoorbaek C et al. Transcriptional regulation of the thyrotropinreleasing hormone gene by leptin and melanocortin signaling. J Clin Invest 2001; 107: 111-120.
45. Song CK, Vaughan CH, Keen-Rhinehart E, Harris RB, Richard D, Bartness TJ. Melanocortin-4 receptor mRNA expressed in sympathetic outflow neurons to brown adipose tissue: neuroanatomical and functional evidence. Am J Physiol Regul Integr Comp Physiol2008; 295: R417-R428.
46. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science1992; 257: 1248-1251.
47. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141.
48. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998; 20: 111-112.
49. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000; 26: 97-102.